Search PubMed⌕ Search

Biomedical subjects

M Rothstein

Publications and source records attributed to M Rothstein.

At least 37 records · Page 2Linked to original sources

Renal tubular acidosis.

Renal tubular acidosis refers to a group of disorders that result from pure tubular damage without concomitant glomerular damage. They could be hereditary (primary) or acquired (secondary to various disease states like sickle cell disease, obstructive uropathy, postrenal transplant, autoimmune disease, or drugs). The hallmark of the disorder is the presence of hyperchloremic metabolic acidosis with, or without, associated defects in potassium homeostasis, a UpH greater than 5.5 in the presence of systemic acidemia, and absence of an easily identifiable cause of the acidemia. There are three physiologic types whose basic defects are impairment of or a decrease in acid excretion, i.e., type 1 (dRTA); a failure in bicarbonate reabsorption, i.e., type 2 (pRTA); and deficiency of buffer or impaired generation of NH4+, i.e., type 4 RTA. Several pathophysiologic mechanisms have been postulated for these various types. pRTA is the least common of all in the adult population. It rarely occurs as an isolated defect. It is frequently accompanied by diffuse proximal tubule transport defects with aminoaciduria, glycosuria, hyperphosphaturia, and so forth (Fanconi syndrome). dRTA is associated with a high incidence of nephrolithiasis, nephrocalcinosis, osteodystrophy, and growth retardation (in children). Osteodystrophy also occurs in pRTA to a lesser degree and is believed to be secondary to hypophosphatemia. Patients with type 4 RTA usually have mild renal insufficiency from either diabetes mellitus or interstitial nephritis. Acute bicarbonate loading will result in a high fractional excretion of bicarbonate greater than 15% (FEHCO3- greater than 15%) in patients with pRTA, but FEHCO3- less than 3% in patients with dRTA. Type I patients will also have a low (U - B) PCO2 with bicarbonate loading. They are also unable to lower their urine pH to less than 5.5 with NH4Cl loading. The treatment of these patients involves avoidance of precipitating factors when possible, treatment of underlying disease, correction of electrolyte imbalance, particularly hypokalemia and hyperkalemia, and most importantly, the use of alkali. This will prevent or reduce all the various complications.

Acid-Base Equilibrium↗

The effects of intraperitoneal calcitriol on calcium and parathyroid hormone.

Parathyroid suppression by intraperitoneal calcitriol (1,25(OH)2D3) during peritoneal dialysis. The purpose of this study was to determine if parathyroid hormone (PTH) suppression could be achieved by increasing calcium mass transfer (Ca MT) with high dialysate Ca (4 mEq/liter) or via intraperitoneal (i.p.) 1,25(OH)2D3 in patients undergoing continuous ambulatory peritoneal dialysis. Eleven patients were dialyzed for two months with standard Ca dialysate (3.5 mEq/liter) followed by two months with 4.0 mEq/liter Ca, then by three months of i.p. 1,25(OH)2D3. During the latter period, patients were randomized to groups whose dialysate contained either 3.5 mEq/liter or 4.0 mEq/liter Ca. We found that 4.0 mEq/liter Ca dialysate more than doubled Ca MT (37 +/- 17 mg/day to 84 +/- 6 mg/day) leading to a modest fall (P less than 0.05) in PTH levels (84 +/- 5.5% of controls). Ionized calcium levels did not change. With i.p. 1,25(OH)2D3, however, ionized calcium rose significantly (P less than 0.001) leading to a decline in PTH levels to 53.9 +/- 7.9% of control values. Serum 1,25(OH)2D3 levels rose from undetectable to 47.7 +/- 7.2 pg/dl (normal range 20 to 35). These studies indicate that increasing Ca MT using a 4.0 mEq/liter Ca dialysate leads to a small reduction in PTH concentrations. On the other hand, i.p. 1,25(OH)2D3 is well absorbed into the systemic circulation, raises ionized calcium levels, and leads to a marked suppression of PTH. Thus, i.p. 1,25(OH)2D3 may be a simple and effective means to suppress secondary hyperparathyroidism in patients undergoing CAPD.

Adult↗

Evidence for the lack of lysosomal involvement in the age-related slowing of protein breakdown in Turbatrix aceti.

Lysosomal proteinase activity increases, whereas the rate of protein degradation decreases in the aged free-living nematode, Turbatrix aceti. The lysosomotropic agents, chloroquine and ammonium chloride have no effect on the rate of protein degradation in either young or old organisms. These findings lend strong support to the idea of a non-lysosomal site of endogenous protein degradation under basal metabolic conditions.

Aging↗

Protein synthesis by liver ribosomes from aged rats.

The age-related decrease in protein synthesis by cell-free systems has been traced to a factor which can be obtained by high salt extraction of young polysomes. Such extracts, when added to old ribosomes in young post-ribosomal supernate, stimulate the level of Poly(U)-directed protein synthesis. Extracts of old polysomes have essentially no effect. The deficient factor is not EF-2 and is highly unlikely to be EF-1, as this component resides almost entirely in the post-ribosomal supernates used in the reaction mixture. Since initiation factors are not necessary for Poly(U)-directed protein synthesis and EF-1 and EF-2 do not appear to be involved, the nature of the soluble factor which is deficient in old ribosomes appears to lie outside of proteins which are commonly implicated in the age-related slowing of protein synthesis.

Aging↗

Altered phosphoglycerate kinase from old rat muscle shows no change in primary structure.

Phosphoglycerate kinase (ATP:3-phospho-D-glycerate 1-phosphotransferase, EC 2.7.2.3) from young and old rat muscle was purified to homogeneity. After ascertaining that each preparation of the enzyme obtained from the latter indeed possessed altered properties, matched pairs of young and old enzymes were subjected to amino acid analysis and peptide mapping by HPLC. Following S-carboxymethylation, the respective young and old enzymes were digested with each of the following three proteinases: trypsin, chymotrypsin and S. aureus V8 proteinase. The corresponding peptides were resolved by reverse-phase HPLC. The peptide patterns obtained from both enzyme forms were identical. Even when the peptides obtained from digestion of phosphoglycerate kinase with S. aureus V8 proteinase were further digested with trypsin, no differences were observed. Comparative amino acid analyses also showed no differences. These results provide direct evidence that there are no changes in the sequence of altered rat muscle phosphoglycerate kinase and support the hypothesis that the differences in properties between the young and old forms of the enzyme result from a conformational modification.

Aging↗

The effect of aging on cell-free protein synthesis in the free-living nematode Turbatrix aceti.

The age-related reduction in cell-free protein synthesis in the free-living nematode Turbatrix aceti is due to a defect in the ribosomes. Addition of young ribosomal wash or use of young medium does not improve the activity of old, run-off ribosomes in the presence of phenylalanine and poly(U). It appears that some of the old ribosomes are incapable of binding the EF-1-GTP-aminoacyl-tRNA complex. These ineffective ribosomes are present in the 80 S (monosomal) fraction. Old ribosomes obtained from polysomes appear to bind normally.

Aging↗

Altered brain phosphoglycerate kinase from aging rats.

Pure phosphoglycerate kinase from old rat brain differs from the "young" enzyme as judged by its greater stability to heat and storage and its resistance to inactivation by protease. Moreover, inactivation of young compared to old brain phosphoglycerate kinase requires different amounts of monospecific antiserum raised against either the young form of muscle or liver phosphoglycerate kinase. Both young and old brain phosphoglycerate kinase are similar with respect to Vmax in the forward and backward directions, Km for different substrates, electrophoretic mobility and average molecular weight. Thus, the properties of young and old brain phosphoglycerate kinase that are similar and those that differ share a common pattern with their young and old counterparts from rat muscle and liver. Kinetic data and immunological response indicate that brain phosphoglycerate kinase is similar if not identical to the muscle enzyme rather than the liver enzyme.

Aging↗

Lack of influence of 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion from normal or hyperplastic glands.

The role of 24,25(OH)2D3 on parathyroid gland function remains controversial. The present studies were performed in vitro using (a) dispersed normal bovine parathyroid cells (bPTC) and (b) dispersed canine PTC (cPTC) prepared from glands of normal dogs, dogs with chronic renal failure (CRF), and dogs with CRF treated with 24,25(OH)2D3, 2.5 micrograms orally every day for more than 6 months. Bovine parathyroid cells were incubated for up to 180 min at 0.5, 1.0, and 3.0 mM external calcium in the presence or absence of 24,25(OH)2D3 (100 or 1000 nM). Similar experiments were conducted with cells incubated for 24 h in the presence of either the ethanol vehicle or 24,25(OH)2D3 (1000 nM). Parathyroid hormone secretion, measured in the supernatant by both C-terminal and N-terminal assays, did not show any differences between control and experimental groups at any time interval. Canine parathyroid cells obtained from uremic animals showed an average threefold increase in the total amount of PTH secreted, on a per cell basis over 180 min at 0.5 mM Ca2+, when compared with normal controls. However, there was no significant difference in PTH secretion at any level of calcium concentration between the cells obtained from parathyroid glands of CRF dogs and 24,25(OH)2D3-treated CRF dogs. Acute exposure to 24,25(OH)2D3 (1000 nM) in vitro of the cells obtained from the glands of CRF dogs also had no effect on PTH secretion. We conclude that 24,25(OH)2D3 has no direct effect on PTH secretion from dispersed parathyroid cells of either normal or uremic animals.

24,25-Dihydroxyvitamin D 3↗

Suppression of parathyroid hormone secretion by aluminum.

The effect of aluminum on parathyroid hormone secretion was examined using collagenase-dispersed bovine parathyroid cells. An increase in the medium aluminum concentration over the range of 0.5 to 2.0 mM, in low calcium medium, progressively inhibited the secretion of radioimmuno-assayable hormone. At 2.0 mM aluminum hormone secretion was inhibited by 68% while high medium calcium, without aluminum, maximally inhibited parathyroid hormone secretion only 39%. Individually, 2.0 mM aluminum or 2.0 mM calcium inhibited isoproterenol-stimulated hormone secretion by 43%. Either metal suppressed basal and isoproterenol-stimulated cyclic AMP levels of the parathyroid cells. That the inhibitory effect of aluminum on parathyroid hormone secretion was not due to an irreversible toxic effect was demonstrated by a restoration of normal secretion when cells were returned to 0.5 mM calcium medium without aluminum. The incorporation of [3H]leucine into total cell protein, parathyroid secretory protein, proparathyroid hormone, or parathyroid hormone was not affected by aluminum. The secretion of radiolabeled protein was, however, inhibited by aluminum. These results suggest that aluminum does not affect protein biosynthesis of the parathyroid cell or the conversion of proparathyroid hormone to parathyroid hormone. Aluminum appears to directly affect the secretion of protein from dispersed parathyroid cells.

Aluminum↗

The effect of aging on rat liver phosphoglycerate kinase and comparison with the muscle enzyme.

Pure liver phosphoglycerate kinase (ATP:3-phospho-D-glycerate 1-phosphotransferase, EC 2.7.2.3) from old rats has been found to be an altered enzyme with certain properties which are dissimilar to those of the enzyme obtained from young animals. Stability during storage, sensitivity to heat, response to antiserum and stability during isoelectric focusing differ. Unchanged are molecular weight, specific activity, Km, reactivity of SH groups, blocked N-terminal residue and leucine for the C-terminal residue. Liver phosphoglycerate kinase differs substantially from the muscle enzyme. Among the differences are stability, heat-sensitivity, Km for 3-phosphoglyceric acid, inactivation by urea and response to antiserum. Nonetheless, a number of properties suggest that the liver and muscle enzymes are similar in structure. Both react with antisera prepared to phosphoglycerate kinase from muscle and liver, respectively. For both enzymes, the N-terminal residue is blocked and the C-terminal amino acid is leucine. The muscle form has been named phosphoglycerate kinase-1 or A. The only previously known isozyme is the testis enzyme, phosphoglycerate kinase-2 or B. We therefore propose that the liver enzyme be known as phosphoglycerate kinase-3 or C.

Aging↗

The factor which aggregates nematode, yeast and liver phosphoglycerate kinase in tRNA.

1. A factor isolated from the free-living nematode, Turbatrix aceti and from yeast, causes aggregation of phosphoglycerate kinase from nematodes, yeast and rat liver. The rat muscle enzyme is not affected. 2. The aggregation factor is either identical to or very similar to tRNA, Pure tRNA from yeast or Escherichia coli, when mixed with nematode, yeast or rat liver phosphoglycerate kinase causes the enzyme to aggregate to higher mol. wt forms. Both the natural factor and tRNA bring about similar changes in the behavior of nematode phosphoglycerate kinase. 3. The tRNA does not remain bound to the enzyme though it appears to cause a sequential aggregation from monomer to tetramer. 4. No conclusion could be reached as to whether the factor plays a physiological role or if it is simply tRNA fortuitously present during purification of the enzyme.

Animals↗

Regenerating liver in aged rats produces unaltered phosphoglycerate kinase.

Pure phosphoglycerate kinase from old rat liver shows altered properties. However, when old animals are partially hepatectomized, the regenerating liver produces the "young" form of the enzyme. By 4 or 5 days after hepatectomy, the enzyme once again becomes "old" in its properties. The results are interpreted as showing that normal enzyme is produced that becomes post-synthetically modified. This interpretation agrees with the idea that in old animals, "young" enzymes become conformationally modified, perhaps because of a slowing of protein turnover.

Aging↗

Effect of aging on enolase from rat muscle, liver and heart.

Muscle enolase (2-phospho-D-glycerate hydrolase, EC 4.2.1.11) and liver enolse from young and old rats have been purified to homogeneity and several properties of the respective young/old pairs, including Km, behavior on polyacrylamide gels, sensitivity to heat and specific activity have been compared. No difference has been detected. On the other hand, the heart isozyme shows an age-related increase in a heat-sensitive form of the enzyme. The results strongly support the idea tht some enzymes become altered in aging animals but others do not.

Aging↗

Altered phosphoglycerate kinase in aging rats.

Pure phosphoglycerate kinase from young and old rat muscle shows substantial differences in properties. Compared to the "young" enzyme, phosphoglycerate kinase isolated from old animals possesses a greater stability to heat and storage, a slower reacting -SH group, an altered UV spectrum, and requires more antiserum prepared to "young" enzyme for 50% inactivation. Km and specific activity are unchanged. Immunotitration experiments show evidence for an age-related alteration of the enzyme in liver and brain, but not in kidney, lung, or heart. Loss of NH2- or COOH-terminal amino acids is not responsible for the observed differences in the properties of "young" and "old" muscle phosphoglycerate kinase. Both forms of the enzyme contain a blocked (presumably acylated) NH2-terminal residue and the sequence of the three COOH-terminal residues (Ala-Val-Leu-COOH) is identical. Moreover, isoelectric focusing of the two enzyme forms of both acrylamide gels and in a sucrose gradient failed to detect evidence of deamidation or other charge-altering differences. We conclude that, like enolase from aged nematodes, muscle phosphoglycerate kinase becomes altered in conformation in old rats.

Aging↗

Altered enolase in aged Turbatrix aceti results from conformational changes in the enzyme.

Young- and old-type enolases (2-phospho-D-glycerate hydrolyase, EC 4.2.1.11) from the free-living nematode Turbatrix aceti can be unfolded in 1.25 M guanidine hydrochloride and subsequently refolded with essentially a quantitative recovery. After refolding, both enolases form an identical or near-identical third type of the enzyme as determined by spectral criteria, sensitivity to heat, immunotitration, and rate of inactivation by bacterial protease. By the same criteria, the refolded enolase is closer in conformation to the native old form of the enzyme than to the young form. The results prove that young and old enolases are conformational isomers and that an in vivo transformation from young to old enzyme takes place by conformational changes without covalent modification. The process may be related to the previously demonstrated slowing of enolase turnover in T. aceti. Errors in sequence cannot be involved in the age-related alteration of the enzyme.

Aging↗